- 全部删除
您的购物车当前为空
PF-05221304 (NSC-170984) 是一种具有口服活性的肝脏靶向乙酰辅酶A 羧化酶 (ACC) 抑制剂,ACC 是脂肪酸合成的限速酶。

PF-05221304 (NSC-170984) 是一种具有口服活性的肝脏靶向乙酰辅酶A 羧化酶 (ACC) 抑制剂,ACC 是脂肪酸合成的限速酶。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 636 | In stock | |
| 5 mg | ¥ 1,590 | In stock | |
| 10 mg | ¥ 2,530 | In stock | |
| 25 mg | ¥ 4,410 | In stock | |
| 50 mg | ¥ 5,930 | In stock | |
| 100 mg | ¥ 7,980 | In stock | |
| 200 mg | ¥ 10,700 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,870 | In stock |
PF-05221304 相关产品
| 产品描述 | PF-05221304 (NSC-170984) is an orally active, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), a rate-limiting enzymes for fatty acid synthesis. |
| 体外活性 | PF-05221304 阻断了人类T细胞向促炎而非抗炎T细胞的极化,并在体外抑制了原代人类星状细胞向肌成纤维细胞的激活,直接显示出其对炎症和纤维生成的影响[1]。 |
| 体内活性 | PF-05221304 在二乙基亚硝胺化学诱导的肝损伤模型以及胆碱缺乏、高脂饲料喂养的大鼠模型中[1],降低了炎症和纤维化的标志物。 |
| 别名 | STAT5 Inhibitor III, R 6238,, NSC 170984, Clesacostat |
| 分子量 | 502.56 |
| 分子式 | C28H30N4O5 |
| CAS No. | 1370448-25-1 |
| Smiles | O=C1CC2(CC3=C1N(C(C)C)N=C3)CCN(C(=O)C=4C=C(N=C(OC)C4)C5=CC=C(C(O)=O)C=C5)CC2 |
| 密度 | 1.36 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 95 mg/mL (189.03 mM), Sonication is recommended. Ethanol: 5 mg/mL (9.95 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容